Need Help?
Copied to clipboard!

Immune-driven response to chemoradiotherapy in POLE-mutated rectal cancer

This study aimed to investigate the chemoradiotherapy response and potential molecular mechanisms underlying chemoradiotherapy response in POLE exonuclease domain mutation-positive rectal cancer.